Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2554776864;76865;76866 chr2:178569493;178569492;178569491chr2:179434220;179434219;179434218
N2AB2390671941;71942;71943 chr2:178569493;178569492;178569491chr2:179434220;179434219;179434218
N2A2297969160;69161;69162 chr2:178569493;178569492;178569491chr2:179434220;179434219;179434218
N2B1648249669;49670;49671 chr2:178569493;178569492;178569491chr2:179434220;179434219;179434218
Novex-11660750044;50045;50046 chr2:178569493;178569492;178569491chr2:179434220;179434219;179434218
Novex-21667450245;50246;50247 chr2:178569493;178569492;178569491chr2:179434220;179434219;179434218
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTG
  • RefSeq wild type template codon: CAC
  • Domain: Ig-135
  • Domain position: 34
  • Structural Position: 51
  • Q(SASA): 0.7704
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/M rs1429730962 -0.296 0.002 N 0.248 0.037 0.0666544352282 gnomAD-2.1.1 8.06E-06 None None None None N None 0 0 None 0 0 None 0 None 4.66E-05 8.9E-06 0
V/M rs1429730962 -0.296 0.002 N 0.248 0.037 0.0666544352282 gnomAD-4.0.0 6.84674E-06 None None None None N None 0 4.47588E-05 None 0 0 None 0 0 6.29978E-06 0 1.65793E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.0832 likely_benign 0.0862 benign -0.518 Destabilizing None N 0.127 neutral N 0.386943177 None None N
V/C 0.5875 likely_pathogenic 0.5863 pathogenic -0.652 Destabilizing 0.356 N 0.399 neutral None None None None N
V/D 0.1978 likely_benign 0.1991 benign -0.243 Destabilizing None N 0.371 neutral None None None None N
V/E 0.1469 likely_benign 0.1568 benign -0.355 Destabilizing 0.029 N 0.48 neutral N 0.359775218 None None N
V/F 0.1538 likely_benign 0.1548 benign -0.709 Destabilizing 0.214 N 0.421 neutral None None None None N
V/G 0.1258 likely_benign 0.1307 benign -0.658 Destabilizing 0.012 N 0.459 neutral N 0.402024485 None None N
V/H 0.3716 ambiguous 0.3722 ambiguous -0.212 Destabilizing 0.864 D 0.469 neutral None None None None N
V/I 0.075 likely_benign 0.0758 benign -0.298 Destabilizing 0.016 N 0.358 neutral None None None None N
V/K 0.1832 likely_benign 0.1988 benign -0.45 Destabilizing 0.072 N 0.487 neutral None None None None N
V/L 0.1107 likely_benign 0.1071 benign -0.298 Destabilizing 0.004 N 0.298 neutral N 0.44851171 None None N
V/M 0.0735 likely_benign 0.0731 benign -0.343 Destabilizing 0.002 N 0.248 neutral N 0.46242237 None None N
V/N 0.1415 likely_benign 0.1409 benign -0.187 Destabilizing 0.12 N 0.499 neutral None None None None N
V/P 0.3509 ambiguous 0.3778 ambiguous -0.336 Destabilizing 0.356 N 0.475 neutral None None None None N
V/Q 0.1676 likely_benign 0.1778 benign -0.436 Destabilizing 0.214 N 0.471 neutral None None None None N
V/R 0.1917 likely_benign 0.2092 benign 0.073 Stabilizing 0.214 N 0.495 neutral None None None None N
V/S 0.1126 likely_benign 0.1132 benign -0.573 Destabilizing 0.016 N 0.419 neutral None None None None N
V/T 0.0865 likely_benign 0.0882 benign -0.583 Destabilizing 0.001 N 0.205 neutral None None None None N
V/W 0.6169 likely_pathogenic 0.6223 pathogenic -0.779 Destabilizing 0.864 D 0.499 neutral None None None None N
V/Y 0.3884 ambiguous 0.4079 ambiguous -0.479 Destabilizing 0.356 N 0.409 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.